Record Quarterly Sales
Second quarter sales of $896 million, a 3% increase year-over-year, described as a company record driven by strength across all three segments and high order backlogs.
Full-Year Record Sales and Elevated Guidance
Updated fiscal 2026 outlook targeting record sales of approximately $3.8 billion with operating margin guidance of 16.0%–16.4% (midpoint 16.2%) and EPS guidance of $3.93–$4.01 (midpoint $3.97), implying ~8% EPS growth at the midpoint versus prior year.
Acquisition to Expand Portfolio (Facet)
Announced acquisition of Facet (expected to add nearly $110 million in sales), characterized as mix-accretive: ~70% recurring regulated replacement revenue, historical high-single-digit growth, higher gross/EBITDA margins than company average, and quick cash generation with expected earnings accretion by year 2.
Life Sciences Outperformance
Life Sciences sales of $80 million, up 16% year-over-year; pretax margin improved to 9.3% from a ~1% loss last year (large margin swing) driven by strong Food & Beverage and Disk Drive performance and focused expense structure.
Mobile Solutions Resilience and China Strength
Mobile Solutions sales $557 million, up 2% (currency-driven). Aftermarket sales $447 million up 1% with high single-digit independent channel growth; China Mobile sales up 18%, marking six consecutive quarters of growth.
Power Generation Demand and Backlogs
Industrial filtration (IFS) sales of $223 million, up 7%, with notably strong Power Generation demand and healthy order books; management reports solid backlogs across several businesses supporting second-half step-up.
Strong Cash/Capital Position and Policy
Net leverage 0.7x (pro forma ~1.7x including Facet), capex guidance $60–$75 million, projected cash conversion 85%–95% (midpoint ~90%), intent to rapidly pay down acquisition-related debt, dividend continued (70th consecutive year paying dividends, 30th consecutive increase).